Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling - PubMed (original) (raw)

Review

Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling

L J Ignarro. Pharmacol Toxicol. 1990 Jul.

Abstract

The interaction between nitric oxide (NO) synthesized in one cell and the haem group of cytosolic guanylate cyclase located in target cells to form NO-haem-guanylate cyclase represents a unique signal transduction mechanism that links extracellular stimuli to the synthesis of cyclic GMP in nearby target cells. Autacoids, neurotransmitters, and macrophage- and neutrophil-activating factors interact with selective extracellular receptors to trigger formation of NO from L-arginine. NO may be viewed as a second messenger. The NO diffuses into adjacent target cells and causes haem-dependent activation of guanylate cyclase, thereby stimulating cyclic GMP accumulation. Guanylate cyclase-bound haem serves as a transducer in transferring the signal from NO to guanylate cyclase. Cyclic GMP acts as a third messenger in causing vascular smooth muscle relaxation, inhibition of platelet aggregation and adhesion, and modulation of macrophage, neutrophil, and other phagocytic cell functions. The unique physical and chemical properties of NO allow it to function as an intercellular modulator within a localized environment. This intercellular or transcellular signaling mechanism involving a common signal transduction mechanism permits the rapid initiation of localized complementary cellular functions leading to increased local blood flow, inhibition of local thrombosis, and modulation of phagocytosis and cytotoxicity.

PubMed Disclaimer

Cited by

A twist on heme signaling.
Spiro T. Spiro T. ACS Chem Biol. 2008 Nov 21;3(11):673-5. doi: 10.1021/cb800269h. ACS Chem Biol. 2008. PMID: 19032089 Free PMC article.
Inhibition of cytochromes P4501A by nitric oxide.
Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim H, Doehmer J. Stadler J, et al. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3559-63. doi: 10.1073/pnas.91.9.3559. Proc Natl Acad Sci U S A. 1994. PMID: 8170947 Free PMC article.
Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.
Schwalm S, Pfeilschifter J, Huwiler A. Schwalm S, et al. Br J Pharmacol. 2010 Aug;160(7):1641-51. doi: 10.1111/j.1476-5381.2010.00818.x. Br J Pharmacol. 2010. PMID: 20649568 Free PMC article.
Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production.
Deliconstantinos G, Villiotou V, Stravrides JC. Deliconstantinos G, et al. Br J Pharmacol. 1995 Mar;114(6):1257-65. doi: 10.1111/j.1476-5381.1995.tb13341.x. Br J Pharmacol. 1995. PMID: 7620717 Free PMC article.
Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23.
Roman V, Dugas N, Abadie A, Amirand C, Zhao H, Dugas B, Kolb JP. Roman V, et al. Immunology. 1997 Aug;91(4):643-8. doi: 10.1046/j.1365-2567.1997.d01-2263.x. Immunology. 1997. PMID: 9378507 Free PMC article.

Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling - PubMed (original) (raw)